Skip to main content
. 2016 Jul 11;33(11):2604–2616. doi: 10.1007/s11095-016-1983-4

Fig. 1.

Fig. 1

IPRLu model profiles for different salt forms of the same parent drug discovery compound expressed as (a) % dose in perfusate, where a 6 fold difference is noted between salt forms at 20 mins and (b) %SDiP i.e. normalised for the amount of dose in solution, where profiles are comparable. HNA = hydroxynapthoate, FB = free base, HCl = hydrochloride salt.